Five-Year LOE Impact Approaches $200bn

Stelara, Eylea, Vyvanse And Xarelto Among Key Targets For Biosimilars And Generics To 2028

 
• By Dave Wallace
  
Purple icon reading $200bn
The impact of LOEs for the leading 10 developed markets from 2024 to 2028 is nearing $200bn • Source: Shutterstock

More from Generics

More from Products